Skip to main content
Equibles

Brevan Howard Capital Management LP

Position in IMUX — Immunic, Inc.

CIK 1512857 ST. HELIER, Y9
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$356,291
+$305,406 QoQ
Shares Held
23,181
+405.7% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 55 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $183,834,510 across 129 Biotechnology names. IMUX ranks #76 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 517,621 $18,318,607
2 MRNA
Moderna, Inc.
 181,105 $12,682,782
3 BBIO
BridgeBio Pharma, Inc.
 155,727 $11,598,546
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 17,622 $8,753,376
5 AXSM
Axsome Therapeutics, Inc.
 31,928 $7,815,015
6 DFTX
Definium Therapeutics, Inc.
 156,812 $7,376,435
7 SNDX
Syndax Pharmaceuticals Inc
 309,065 $6,756,160
8 INCY
Incyte Corp
 45,270 $5,131,807

All Filings in IMUX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $356,291 23,181
2026-03-31 $50,885 45,843